A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Clinical trial NCT04172675 · COMPLETED
Trial details
- NCT number
- NCT04172675
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-28
- Primary completion
- 2024-07-12
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.